Assessment and outcome of hospitalized patients during delta variant COVID-19 pandemic: A multicenter international study.
| Autor: | Amer FA; Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt. egyamer@yahoo.com., Saeed MA; Viral Infection Working Group of International Society of Antimicrobial Chemotherapy VIWG/ISAC., Wagih Shaltout S; Department of Tropical Medicine, Port Said University, Port Said, Egypt., Nofal HAE; Department of Public Health and Preventive Medicine, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Nafae RM; Department of Pulmonary Medicine, Zagazig Faculty of Medicine, Zagazig, Egypt., Arslan K; Department of Internal Medicine, Sancaktepe Sehit Prof Dr Ilhan Varank Training and Research Hospital, Istanbul, Turkey., Tanoglu A; Viral Infection Working Group of International Society of Antimicrobial Chemotherapy VIWG/ISAC., Nechifor M; Viral Infection Working Group of International Society of Antimicrobial Chemotherapy VIWG/ISAC., Luca C; Viral Infection Working Group of International Society of Antimicrobial Chemotherapy VIWG/ISAC., Al-Kadhim ZHA; MBChB. A.B.M. Kazemia Education Hospital, Baghdad, Iraq., Mosallem A; Department of Anesthesia and Surgical Intensive Care, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Hammad NM; Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of infection in developing countries [J Infect Dev Ctries] 2022 Nov 29; Vol. 16 (11), pp. 1715-1725. Date of Electronic Publication: 2022 Nov 29. |
| DOI: | 10.3855/jidc.16696 |
| Abstrakt: | Introduction: To date, the world has experienced four waves of the Coronavirus disease- 19 (COVID-19) pandemic. Patients infected during the era of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant were the subject of this study. The objectives were to describe their clinical manifestations, explain their laboratory and radiological findings, conclude factors contributing to clinical outcomes, and evaluate treatment protocols. Methodology: Relevant data were collected retrospectively from records of patients admitted to six referral centers in four countries. Data included sociodemographic patterns, symptoms, associated comorbidities, physical examination, laboratory and radiologic findings, treatment received, and patient outcomes. Results: Data analysis identified symptomatology and variables related to acquisition and infection outcome. The most prevalent symptoms were cough (81.5%), body aches (74.1%), and fever (71.6%). Independent risk factors for mortality were age, vomiting, epigastric pain, diabetes, obesity, oxygen saturation less than 90%, leukocytosis, neutrophilia, lymphopenia, thrombocytopenia, elevated creatinine, high glucose level, lung ground glass opacities with consolidation, affection of four lobes and bilateralism. Neither d-dimer nor lactate dehydrogenase nor ferritin foretells death possibility. The efficacy of the medications used was convenient. Conclusions: Assessing the clinical features of different COVID-19 waves, identifying predictors of outcomes, and concluding the efficacy of treatment protocols provide insight into patients' responses and viral behaviors, which help in the proper diagnosis and treatment of subsequent surges. Competing Interests: No Conflict of Interest is declared (Copyright (c) 2022 Fatma Abdelaziz Amer, Maysaa Abdallah Saeed, Shaker Wagih Shaltout, Hanaa Abu Elazayem Nofal, Ramadan Mahmoud Nafae, Kadem Arslan, Alpaslan Tanoglu, Mihai Nechifor, Catalina Luca, Zaid Hashim Ali Al-kadhim, Ahmed Mosallem, Noha Mohammed Hammad.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|